If you're considering GLP-1 therapy or currently experiencing digestive challenges, understanding the mechanism behind these effectsand identifying your individual risk factorscan support more informed conversations with your healthcare provider and help guide dietary and dosing adjustments
Cagrilintide has similar GI tolerability, with one important difference: it causes more severe sickness at the start of treatment, which is thought to be because it strongly slows down stomach motility
The powder format allows researchers to prepare controlled concentrations for experimental use
Motility Is Key (Seriously, Read This Twice) If youre not pooping, youre fermenting
But as you may be aware, Novo Nordisk and its stock have fallen from the heights it was at just a couple of years ago
Patients should monitor symptoms and adjust accordingly